Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.65 |
| ▸ | EYA2 | O00167 | 1/20 | 0.65 |
| ▸ | APP | P05067 | 1/20 | 0.65 |
| ▸ | ACE | P12821 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 3/20 | 0.62 |
| ▸ | BLM | P54132 | 2/20 | 0.62 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.62 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | DRD1 | P21728 | 1/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.62 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.62 |
| ▸ | DRD3 | P35462 | 1/20 | 0.62 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.62 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3930821 | 0.97 | TDP1 (0.62) | TDP1EYA2APPACETSHR | |
| SCHEMBL1504096 | 0.88 | TDP1 (0.56) | TDP1EYA2APPACETSHR | |
| SCHEMBL2471304 | 0.80 | TDP1 (0.59) | TDP1EYA2APPACETSHR | |
| Edetic Acid SCHEMBL1373 | 0.80 | TDP1 (1.00) | TDP1EYA2APPACETSHR | |
| Edetic Acid SCHEMBL16714076 | 0.80 | TDP1 (1.00) | TDP1EYA2APPACETSHR | |
| Edetic Acid SCHEMBL15136 | 0.80 | TDP1 (1.00) | TDP1EYA2APPACETSHR | |
| Edetic Acid SCHEMBL3035039 | 0.80 | TDP1 (1.00) | TDP1EYA2APPACETSHR | |
| Edetic Acid SCHEMBL8607480 | 0.80 | TDP1 (1.00) | TDP1EYA2APPACETSHR | |
| Edetic Acid SCHEMBL8624198 | 0.80 | TDP1 (1.00) | TDP1EYA2APPACETSHR | |
| Edetic Acid SCHEMBL2010607 | 0.77 | TDP1 (0.93) | TDP1EYA2APPACETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190003999-A1 | Grid Coatings for Capture of Proteins and Other Compounds | PURDUE RESEARCH FOUNDATION (US) | 2019-01-03 | — | — | US | claimed |
| WO-2017106797-A1 | GRID COATINGS FOR CAPTURE OF PROTEINS AND OTHER COMPOUNDS | PURDUE RESEARCH FOUNDATION (US) | 2017-06-22 | — | — | WO | claimed |
| US-8569197-B2 | Process for preparing a reforming catalyst comprising a support, a group VIIIB metal and a group VIIB metal | IFP Energies Nouvelles (FR) | 2013-10-29 | — | — | US | claimed |
| EP-2222399-B1 | METHOD FOR PREPARING A REFORMING CATALYST INCLUDING A SUBSTRATE, A METAL OF GROUP VIII AND A METAL OF GROUP VIIB | IFP Energies Nouvelles (FR) | 2013-09-18 | — | — | EP | claimed |
| US-20090143224-A1 | PROCESS FOR PREPARING A REFORMING CATALYST COMPRISING A SUPPORT, A GROUP VIIIB METAL AND A GROUP VIIB METAL | IFP (FR) | 2009-06-04 | — | — | US | claimed |
| US-20020049190-A1 | Pharmaceutical compositions comprising metal complexes | ANORMED INC. (CA) | 2002-04-25 | — | — | US | claimed |
| EP-1163247-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING METAL COMPLEXES | ANORMED INC. (CA) | 2001-12-19 | — | — | EP | claimed |
| WO-2000056743-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING METAL COMPLEXES | ANORMED INC. (CA) | 2000-09-28 | — | — | WO | claimed |
| US-5068429-A | METHOD OF PURIFICATION OF THE OXALIC ACID DIAMIDE | ENICHEM ANIC S.P.A. (IT) | 1991-11-26 | — | — | US | claimed |
| EP-0245632-B1 | METHOD OF PURIFICATION OF THE OXALIC ACID DIAMIDE | ENICHEM ANIC S.p.A. (IT) | 1990-09-26 | — | — | EP | claimed |
| US-4285575-A | USING AN ELECTROCHROMIC ELECTROLYTE CONTAINING A CARBOXYLIC-CONTAINING COMPLEXING AGENT, A FERROUS SALT, A METAL SALT, AND A CHROMOGEN; DURABILITY | CANON KABUSHIKI KAISHA (JP) | 1981-08-25 | — | — | US | claimed |
| US-4212518-A | ELECTROCHROMIC CELL | CANON KABUSHIKI KAISHA (JP) | 1980-07-15 | — | — | US | claimed |
| US-20240304351-A1 | SEPARATION OF METAL IONS BY LIQUID-LIQUID EXTRACTION | UNIV CALIFORNIA (US) | 2024-09-12 | — | — | US | disclosed |
| US-12002595-B2 | Separation of metal ions by liquid-liquid extraction | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-06-04 | — | — | US | disclosed |
| US-11965851-B2 | Grid coatings for capture of proteins and other compounds | PURDUE RESEARCH FOUNDATION (US) | 2024-04-23 | — | — | US | disclosed |
| US-10989681-B2 | Grid coatings for capture of proteins and other compounds | PURDUE RESEARCH FOUNDATION (US) | 2021-04-27 | — | — | US | disclosed |
| EP-0245632-B1 | METHOD OF PURIFICATION OF THE OXALIC ACID DIAMIDE | ENICHEM ANIC S.p.A. (IT) | 1990-09-26 | — | — | EP | disclosed |
| EP-0245632-A2 | Method of purification of the oxalic acid diamide | ENICHEM ANIC S.p.A. (IT) | 1987-11-19 | — | — | EP | disclosed |
| US-4285575-A | USING AN ELECTROCHROMIC ELECTROLYTE CONTAINING A CARBOXYLIC-CONTAINING COMPLEXING AGENT, A FERROUS SALT, A METAL SALT, AND A CHROMOGEN; DURABILITY | CANON KABUSHIKI KAISHA (JP) | 1981-08-25 | — | — | US | disclosed |
| US-4212518-A | ELECTROCHROMIC CELL | CANON KABUSHIKI KAISHA (JP) | 1980-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10989681-B2 | Grid coatings for capture of proteins and other compounds | CD2BP2, CDC37, DSTN | TDP1 1630/4885EYA2 990/4885APP 3595/4885 |
| US-11965851-B2 | Grid coatings for capture of proteins and other compounds | CD2BP2, CDC37, CD68 | TDP1 1855/4885EYA2 922/4885APP 2913/4885 |
| US-12002595-B2 | Separation of metal ions by liquid-liquid extraction | SLC39A14, SLC39A11, SLC39A7 | TDP1 2392/4885EYA2 2820/4885APP 4311/4885 |
| US-20020049190-A1 | Pharmaceutical compositions comprising metal complexes | CFD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, F12 | TDP1 3584/4885EYA2 914/4885APP 1616/4885 |
| US-20240304351-A1 | SEPARATION OF METAL IONS BY LIQUID-LIQUID EXTRACTION | SLC39A14, SLC39A11, SLC39A7 | TDP1 2392/4885EYA2 2820/4885APP 4311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.